Supported by: Alison Harris*, Alexander Stewart*, Miles Briggs*, Michelle Ballantyne*, Gordon Lindhurst*, Peter Chapman*, Murdo Fraser* *S5M-20650 Miles Briggs: Improving Diagnosis of Pre-eclampsia—That the Parliament understands that the condition pre-eclampsia affects at least 6% of all pregnancies in Scotland, and that 70% of women admitted to hospital with suspected pre-eclampsia do not actually have the condition, which it considers results in cost implications for the healthcare system and unnecessary stress and inconvenience for the women and families involved; further understands that, in 2016, the National Institute for Clinical Excellence (NICE) published guidelines recommending blood testing of placental growth factor (PlGF), stating that PlGF-based testing "can help rule out the condition in women presenting with suspected pre-eclampsia", and that this testing is currently being implemented in NHS England; believes that PlGF-based testing is not routinely used in Scotland despite repeated calls for its implementation by the charity, Action on Pre-eclampsia; considers that there is a disparity in care for pregnant women in Scotland, Thursday 30 January 2020 13 Today's Business Future Business Motions & Questions Legislation Other Gnothaichean an-diugh Gnothaichean ri teachd Gluasadan agus Ceistean Reachdas Eile Motions | Gluasadan including in the Lothian region, compared with England, and notes the calls on the Scottish Government to address what it sees as this disparity.